Results for tag: "Posaconazole"

Posaconazole is an antifungal drug used to treat a variety of fungal infections, including those caused by Aspergillus and Candida species. It is a triazole antifungal, which works by inhibiting the synthesis of ergosterol, a key component of fungal cell membranes. Posaconazole is used to treat serious fungal infections in patients who are immunocompromised, such as those with HIV/AIDS, cancer, or organ transplant recipients. It is also used to prevent fungal infections in patients who are at high risk of developing them. Posaconazole is available in both oral and intravenous formulations, and is typically used in combination with other antifungal drugs. It is generally well tolerated, with the most common side effects being nausea, vomiting, and diarrhea. Posaconazole is a key drug in the infectious diseases drugs market, as it is used to treat a variety of serious fungal infections. It is an important treatment option for immunocompromised patients, and is also used to prevent fungal infections in high-risk patients. Companies in the posaconazole market include Merck & Co., Inc., Pfizer, Inc., Astellas Pharma, Inc., and Dr. Reddy's Laboratories. Show Less Read more